BIOGEN IDEC INC. - CAMBRIDGE OPERATIONS
- 14 CAMBRIDGE CENTER
02142 CAMBRIDGE, MA
GEO: 42.365815, -71.086846
Phone: 001 (617) 679-2000
Fax: 617-679-2617
www.biogenidec.com
Short profile:
At Biogen Idec, science and innovation don't stop in the research lab. Process sciences and manufacturing are crucial to the success of our mission.
Our capabilities for protein manufacturing are world-class in quality and scale. Biogen Idec has expertise in protein expression in mammalian cells and in the manufacturing across a range of biologics from monoclonal antibodies to interferon proteins. We also have process sciences capability for cell culture and downstream processing.
Detailed description:
As for capacity, Biogen Idec is one of a few biotechnology companies with dedicated biological bulk-manufacturing facilities. These facilities include a 250, 000-square-foot large-scale manufacturing (LSM) plant in Research Triangle Park (RTP), NC. The LSM has 90, 000 liters of bioreactor capacity and is one of the largest biologic manufacturing facilities of its kind in the world. This facility has already received industry recognition for its exceptional design, innovative modular construction methods, and strong safety record.
The company also operates other licensed manufacturing facilities in RTP and Cambridge, MA, and has one of the leading capacities for biologics manufacturing in the biotechnology industry. This represents sufficient manufacturing capacity for Biogen Idec's own growing pipeline of products, as well as the products of potential partners. In fact, Biogen Idec's leadership in biologics manufacturing makes the company an ideal collaborator for the co-development of innovative therapeutics.
Keywords:
biologics manufacturing, genetic technology, development, produce, medicine, interferon beta, treat cancer, research, Biotechnology industry, Pharmaceuticals, Pharmaceutics, global biotechnology, oncology, neurology, immunology, manufacturing plant, commercialization, treatments, scientific discoveries, Quality, Integrity, Honesty, sclerosis, therapies, Hemophilia, cardiopulmonary therapeutics
